Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
512.00    -10.00 (-1.92%)
Bid:
508.00
Ask:
511.00
Spread: 3.00 (0.591%)
Market Cap: £502.80m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

New Incentive Plan

12 Oct 2016 11:00

RNS Number : 1120M
Galliford Try PLC
12 October 2016
 

Galliford Try plc

(the "Company")

 

Proposed performance conditions for first awards under new Long Term Incentive Plan (the "Plan")

 

The Company intends to make its first awards under a new long-term incentive plan shortly following and contingent on shareholder approval at the 2016 Annual General Meeting for the new Plan.

 

The Company can now confirm that the performance conditions proposed for such first awards will be structured as previous grants and comprise measures of earnings per share ("EPS") and total shareholder return ("TSR") in respect of a performance period comprising three consecutive financial years of the Company starting with the current year ending 30 June 2017.

 

The vesting of up to 50% of each base award will be based on EPS performance, 15% of the base award will vest for aggregate EPS of 489 pence over the performance period, increasing to 50% of each base award vesting for aggregate EPS of 568 pence.

 

7.5% of each base award will vest for the Company's TSR performance against a Housebuilding Comparator Group ranking equal to median performance, increasing to 25% vesting of each base award if the Company's TSR is 24% higher than that of the median ranked company in such comparator group.

 

Vesting for relative TSR performance against the Housebuilding Comparator Group can increase to a maximum of 75% of each base award for the Company achieving a TSR that is 75% higher than the median ranked comparator company. Any vesting above 25% of each base award in relation to such TSR however also requires the maximum EPS target noted above to have been achieved.

 

The vesting of up to 75% of each base award will be based on the Company's TSR performance over the performance period relative to the TSRs over the same period of the companies within a Construction Comparator Group. Vesting under such measure will be calculated on the same basis as described above in relation to the Housebuilding Comparator Group but by reference to the Construction Comparator Group.

 

In aggregate 200% of each base award may vest subject to the terms and conditions of the Plan.

 

Housebuilding Comparator Group:

 

Barratt Developments plc, Bellway plc, Bovis Homes Group plc, Countryside plc, Crest Nicholson Holdings plc, McCarthy & Stone plc, M J Gleeson Group plc, Persimmon plc, Redrow plc, Taylor Wimpey plc and The Berkeley Group Holdings plc.

 

Construction Comparator Group:

 

Balfour Beatty plc, Carillion plc, Kier Group plc, Morgan Sindall Group plc, Costain Group plc, Keller Group plc and Henry Boot plc.

 

For further enquiries:

 

Galliford Try plc

Kevin Corbett, Company Secretary

01895 855001

Clara Melia, Investor Relations

07748 171 236

Tulchan Communications

James Macey White

0207 353 4200

Martin Pengelley

Matt Low

 

 

 

Galliford Try plc is a leading UK housebuilding and construction group. It is listed on the London Stock Exchange and a member of the FTSE 250. Housebuilding - through our Linden Homes and Galliford Try Partnerships and Regeneration businesses - sells distinctive homes to the public and affordable homes to housing associations and local authority providers. The construction business carries out building and infrastructure work across the UK with clients ranging from major Government departments through to regulated utilities and private sector companies. At the end of the last financial year to 30 June 2016, the Group generated revenues of £2.5 billion.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKBLBFQBFXFBB
Date   Source Headline
23rd Oct 202410:00 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSTransaction in Own Shares
22nd Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 202411:30 amRNSAnnual Financial Report
16th Oct 20241:00 pmRNSDirector/PDMR Shareholding
15th Oct 20247:00 amRNSTransaction in Own Shares
14th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 202410:30 amRNSDirector/PDMR Shareholding
11th Oct 20247:00 amRNSTransaction in Own Shares
10th Oct 20247:00 amRNSTransaction in Own Shares
9th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 20243:50 pmRNSDirector/PDMR Shareholding
8th Oct 20243:45 pmRNSDirector/PDMR Shareholding
8th Oct 20243:45 pmRNSDirector/PDMR Shareholding
8th Oct 20247:00 amRNSTransaction in Own Shares
4th Oct 20245:25 pmRNSDirector/PDMR Shareholding
4th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:02 amRNSLaunch of Share Buyback Programme
3rd Oct 20247:00 amRNSFinal Results
30th Sep 20243:00 pmRNSTotal Voting Rights
24th Sep 20247:00 amRNSContract
23rd Sep 20247:00 amRNSContract
20th Sep 20248:44 amRNSNotification of Full Year Results
16th Sep 20247:01 amRNS2024 Full Year Results: Revised Publication Date
2nd Sep 20242:30 pmRNSDirector Declaration
2nd Sep 202410:30 amRNSTotal Voting Rights
27th Aug 20244:14 pmRNSBlock listing Interim Review
16th Aug 20249:30 amRNSContract
31st Jul 20244:00 pmRNSTotal Voting Rights
24th Jul 202410:30 amRNSDirector Declaration
23rd Jul 20247:00 amRNSContract
11th Jul 20247:00 amRNSTrading Statement
28th Jun 202411:00 amRNSTotal Voting Rights
13th Jun 20247:00 amRNSContract
31st May 20244:00 pmRNSTotal Voting Rights
31st May 20247:00 amRNSContract
23rd May 20247:00 amRNSCapital Markets Event
30th Apr 20244:00 pmRNSTotal Voting Rights
23rd Apr 20244:00 pmRNSDirector/PDMR Shareholding
10th Apr 20245:00 pmRNSHolding(s) in Company
5th Apr 202411:00 amRNSTotal Voting Rights
28th Mar 20247:00 amRNSDirectorate Change
8th Mar 20244:00 pmRNSDirector/PDMR Shareholding
6th Mar 20247:00 amRNSHalf-year Report
4th Mar 20244:00 pmRNSTotal Voting Rights
1st Mar 20247:00 amRNSDirectorate Change
26th Feb 20246:03 pmRNSBlock listing Interim Review
22nd Feb 20247:00 amRNSContract
17th Jan 20247:00 amRNSTrading Statement
30th Nov 20234:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.